Bioprinting technique creates thick 3D tissues composed of human stem cells and embedded vasculature, with potential applications in drug testing and regenerative medicine
A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School for Engineering and Applied Sciences (SEAS) has invented a method for 3D bioprinting thick vascularized tissue constructs composed of human stem cells, extracellular matrix, and circulatory channels lined with endothelial blood vessel cells. The resulting network of vasculature contained within these deep tissues enables fluids, nutrients and cell growth factors to be controllably perfused uniformly throughout the tissue. The advance is reported March 7 in the journal Proceedings of the National Academy of Sciences.
“This latest work extends the capabilities of our multi-material bioprinting platform to thick human tissues, bringing us one step closer to creating architectures for tissue repair and regeneration,” says Wyss Core Faculty member Jennifer A. Lewis, Sc.D., senior author on the study, who is also the Hansörg Wyss Professor of Biologically Inspired Engineering at SEAS.
To date, scaling up human tissues built of a variety of cell types has been limited by a lack of robust methods for embedding life-sustaining vascular networks. Building on their earlier work, Lewis and her team have now increased the tissue thickness threshold by nearly tenfold, setting the stage for future advances in tissue engineering and repair. The method combines vascular plumbing with living cells and an extracellular matrix, enabling the structures to function as living tissues. In the study, Lewis and her team showed that their 3D bioprinted tissues could sustain and function as living tissue architectures for upwards of six weeks.
In the study, Lewis’ team demonstrated the 3D printing of one centimeter-thick tissue containing human bone marrow stem cells surrounded by connective tissue. By pumping bone growth factors through the supporting vasculature lined with the same endothelial cells found in our blood vessels, the team induced cell development toward bone cells over the course of one month.
“This research will help to establish the fundamental scientific understanding required for bioprinting of vascularized living tissues,” Zhijian Pei, National Science Foundation Program Director for the Directorate for Engineering Division of Civil, Mechanical and Manufacturing Innovation, which funded the project. “Research such as this enables broader use of 3-D human tissues for drug safety and toxicity screening and, ultimately, for tissue repair and regeneration.”
Learn more: Scaling up tissue engineering
The Latest on: Bioprinting
via Google News
The Latest on: Bioprinting
- 3D bioprinting of tissue-specific osteoblasts and endothelial cells to model the human jawboneon March 1, 2021 at 4:58 am
Over the past decades, tissue engineering has made astounding progress in developing physiological models of human tissues with ever-growing sophistication and complexity. Particularly 3D bioprinting, ...
- Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplantson February 25, 2021 at 6:33 am
CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announced that on February 24, 2021 it received a notice from Lung Biotechnology, a United Therapeutics ...
- 3D Bioprinting Market Trends 2020 | Industry Growth, Size, Share, Demand and Future Scope 2027on February 25, 2021 at 5:50 am
Ltd. 3D Bioprinting Market by Type (Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, Others) Application (Medical, Dental, Biosensors, Consumer/Personal Product Testing, Bioinks ...
- 3D Bioprinting Market Demand, Growth Challenges, Industry Analysis And Forecasts To 2029on February 23, 2021 at 9:15 pm
The market research report on the Global 3D Bioprinting Market offered by Straits Research, analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the ...
- US 3D Bioprinting Market Size | Share, Current Trends, Advanced Technology with Research Development Report to 2027on February 22, 2021 at 2:01 am
Pune, Maharashtra, India, February 22 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:3D Bioprinting Market is valued at around USD 484.50 Million in 2017 and is evaluated to ...
- Global 3D Bioprinting Market to Exhibit a Decent CAGR of 16.01% and Hit USD 4.8 Billion by 2030on February 17, 2021 at 11:16 pm
The global 3D Bioprinting market size is expected to be worth around US$ 4.8 billion by 2030, according to a new report by Vision Research Reports. The global 3D Bioprinting market size was valued at ...
- New bioprinting technique allows for complex microtissueson February 17, 2021 at 5:41 am
Bioprinting is currently used to generate model tissues for research and has potential applications in regenerative medicine. Existing bioprinting techniques rely on printing cells embedded in ...
via Bing News